Related references
Note: Only part of the references are listed.Age, Neuropathology, and Dementia
George M. Savva et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Epidemiological Pathology of Dementia: Attributable-Risks at Death in the Medical Research Council Cognitive Function and Ageing Study
Fiona E. Matthews et al.
PLOS MEDICINE (2009)
Distinct pools of β-amyloid in Alzheimer disease-affected brain -: A clinicopathologic study
Joshua R. Steinerman et al.
ARCHIVES OF NEUROLOGY (2008)
Amyloid β protein dimer-containing human CSF disrupts synaptic plasticity:: Prevention by systemic passive immunization
Igor Klyubin et al.
JOURNAL OF NEUROSCIENCE (2008)
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Ganesh M. Shankar et al.
NATURE MEDICINE (2008)
A beta Oligomers - a decade of discovery
Dominic M. Walsh et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Cohort profile: The Medical Research Council Cognitive Function and Ageing Study (CFAS)
Carol Brayne et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2006)
Amyloid-β oligomers are inefficiently measured by enzyme-linked immunosorbent assay
C Stenh et al.
ANNALS OF NEUROLOGY (2005)
Alzheimer's disease is a synaptic failure
DJ Selkoe
SCIENCE (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Targeting small Aβ oligomers:: the solution to an Alzheimer's disease conundrum?
WL Klein et al.
TRENDS IN NEUROSCIENCES (2001)
The oligomerization of amyloid β-protein begins intracellularly in cells derived from human brain
DM Walsh et al.
BIOCHEMISTRY (2000)
Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline
J Näslund et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
